Table 1.
Baseline Characteristics of Study Patients
| Patient # | Age, Sex | ECOG PS | # Prior Rx* | Serum CA19.9 Level | Liver Lesions | Lung Lesions | Peritoneal Disease/Ascites |
|---|---|---|---|---|---|---|---|
| 1 | 44M | 0 | 3 | 9,187 | ✓ | ✓ | |
| 2 | 65M | 1 | 3 | NL | ✓ | ✓ | |
| 3 | 69M | 1 | 1 | 351 | ✓ | ✓ | |
| 4 | 59F | 1 | 2 | 1,699 | ✓ | ✓ | |
| 5 | 59F | 0 | 2 | 171,630 | ✓ | ✓ | |
| 6 | 74M | 1 | 2 | 9,747 | ✓ | ✓ | ✓ |
| 7 | 69F | 0 | 1 | 376 | ✓ | ||
| 8 | 65F | 1 | 1 | NL | ✓ | ✓ | ✓ |
| 9 | 64M | 1 | 2 | 618 | ✓ | ✓ | ✓ |
| 10 | 44F | 2 | 2 | 2,864 | ✓ | ✓ | |
| 11 | 67M | 1 | 2 | 3,824 | ✓ | ✓ | |
| 12 | 67F | 1 | 2 | 12,668 | ✓ | ✓ | ✓ |
| 13 | 60F | 1 | 1 | 3,707 | ✓ | ✓ |
Notes: ECOG PS: ECOG Performance Score (scale from 0 to 4; 0= best, with no impairments; 4= bedridden); # Prior Rx = number of prior lines of therapy;
*
prior therapy includes radiation if given separately from chemotherapy;
NL = normal; NA = not available.